VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CLXThe Clorox Company
$99.96$12.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCLXCash Flow

The Clorox Company (CLX) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow margin swung from -9.9% to 12.5% across recent quarters, with the strongest periods coinciding with large working capital inflows, which may overstate the underlying run-rate of cash generation.

Income StatementBalance SheetCash FlowRatios

CLX Cash Flow Statement

Annual statement

CLX Cash Flow Statement

The Clorox Company (CLX) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMJun'26Jun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97
Cash from Operations662M612M981M695M1.16B786M1.28B1.55B992M974M868M778M874M767M775M612M698M819M738M730M709M522M765M899M803M876M747M658M588M312.7M362.1M
Operating CF Margin %-9.11%13.81%9.8%15.67%11.06%17.38%23%15.96%15.9%14.53%13.5%15.46%13.91%13.78%11.19%13.34%15.65%13.54%13.84%14.63%11.24%17.43%20.79%19.38%21.57%19.14%16.12%14.69%11.41%14.3%
Operating CF Growth %-3.87%-37.61%41.15%-39.98%47.33%-38.4%-17.46%55.85%1.85%12.21%11.57%-10.98%13.95%-1.03%26.63%-12.32%-14.77%10.98%1.1%2.96%35.82%-31.76%-14.91%11.96%-8.33%17.27%13.53%11.9%88.04%-13.64%-10.97%
Net Income677M601M824M292M161M471M719M939M820M823M703M648M606M579M573M543M287M526M472M461M501M443M517M490M461M357M323M394M246M350M300M
Depreciation & Amortization265M247M219M235M236M224M211M180M180M166M163M165M169M180M182M178M173M185M190M205M192M188M190M197M191M190M225M201M202M137.6M126.4M
Stock-Based Compensation47M48M81M74M73M52M50M50M43M53M51M45M32M36M35M27M32M60M58M000000000000
Deferred Taxes18M81M-18M-100M-149M5M-32M-2M-20M-23M-35M5M-16M-10M-11M-12M73M24M-1M-42M-15M-28M-45M26M100M-27M-41M-16M-29M32.2M2.1M
Other Non-Cash Items-467M-483M86M435M483M133M339M30M-29M44M30M11M-26M-13M15M-44M278M40M82M52M74M129M107M106M105M152M78M18M77M-1M-6M
Working Capital Changes107M118M-211M-241M354M-99M-11M349M-2M-88M-47M-96M109M-7M-23M-80M-145M-38M-82M7M-43M-210M8M91M-62M178M162M56M84M-157.7M-12M
Change in Receivables75M151M-145M-34M-13M-84M82M-27M-32M-24M-1M-52M6M20M-10M-52M-33M-21M-10M-8M-15M-29M33M8M19M3M123M-10M24M-76M-27M
Change in Inventory-20M-71M63M55M58M-18M-282M50M-7M-21M-19M-45M-25M1M-11M1M-37M2M0-26M-8M26M-17M-35M-11M3M90M-55M40M-38.9M-24.3M
Change in Payables10M38M-124M-140M157M-47M311M291M17M-47M-34M57M93M-12M-29M10M-52M00000000000000
Cash from Investing-2.3B-2.3B-94M-175M-223M-229M-452M-252M-196M-859M-205M-430M-106M-138M-55M-277M544M-231M-197M-1.08B-268M-161M-154M-236M-193M-109M-336M-260M-313M-310.2M-572.6M
Capital Expenditures-209M-207M-220M-212M-228M-251M-331M-254M-206M-194M-231M-172M-125M-138M-194M-192M-228M-203M-197M-170M-147M-180M-151M-172M-205M-177M-192M-158M-292M-247.4M-95.2M
CapEx % of Revenue2.9%3.08%3.1%2.99%3.09%3.53%4.51%3.78%3.32%3.17%3.87%2.99%2.21%2.5%3.45%3.51%4.36%3.88%3.61%3.22%3.03%3.88%3.44%3.98%4.95%4.36%4.92%3.87%7.29%9.02%3.76%
Acquisitions-2.1B-2.1B128M17M00-85M00-681M0-290M000-93M747M-19M0-913M-123M-16M0-13M00-126M-120M000
Investments-------------------------------
Other Investing11M10M-2M20M5M22M-36M2M10M16M26M32M19M-1M135M8M25M-11M-1M1M2M35M-3M-53M10M59M-18M18M-21M-62M-15M
Cash from Financing1.66B1.67B-924M-655M-753M-689M-1.39B-523M-815M-399M-645M-316M-696M-592M-685M-321M-1.08B-706M-540M380M-456M-462M-552M-605M-617M-833M-407M-285M-245M-13.8M220.8M
Debt Issued (Net)2.44B2.56B0-45M-188M-83M096M189M277M-125M126M-128M-60M-355M133M-213M-354M-323M1.44B-237M-233M1.7B-282M11M-4M-210M-78M-43M173M573M
Equity Issued (Net)-163M-279M-306M1M33M-20M-802M-86M-514M-226M-108M-44M-183M-164M5M-139M-562M-70M41M-829M-36M-56M-2.19B-109M-445M-377M2M-32M31M-45M-57M
Dividends Paid-602M-602M-602M-595M-583M-571M-558M-533M-490M-450M-412M-398M-385M-368M-335M-315M-303M-282M-258M-228M-183M-173M-201M-229M-193M-196M-199M-189M-162M-132.4M-120M
Share Repurchases-127M-256M-332M00-25M-905M-248M-661M-271M-183M-254M-434M-260M-128M-225M-655M-150M0-868M-155M-135M-2.28B-220M-486M-412M-10M-135M-33M-109M-99M
Other Financing-16M-16M-16M-16M-15M-15M-31M000000000000000132M15M10M-256M00-100M00
Net Change in Cash14M-23M-35M-161M184M-138M-555M766M-21M-287M17M19M53M30M32M8M172M-119M-8M32M-10M-101M61M60M-5M-74M-3M113M30M-13.8M220.8M
Free Cash Flow453M405M761M483M930M535M945M1.29B786M780M637M606M749M629M581M420M470M616M541M560M562M342M614M727M598M699M555M500M296M65.3M266.9M
FCF Margin %6.3%6.03%10.71%6.81%12.59%7.53%12.87%19.22%12.65%12.74%10.66%10.52%13.24%11.41%10.33%7.68%8.98%11.77%9.93%10.62%11.59%7.36%13.99%16.81%14.43%17.21%14.22%12.25%7.39%2.38%10.54%
FCF Growth %-28.77%-46.78%57.56%-48.06%73.83%-43.39%-26.86%64.38%0.77%22.45%5.12%-19.09%19.08%8.26%38.33%-10.64%-23.7%13.86%-3.39%-0.36%64.33%-44.3%-15.54%21.57%-14.45%25.95%11%68.92%353.29%-75.53%-17.09%
FCF per Share3.713.326.123.877.494.327.4210.126.065.934.844.605.644.774.373.173.404.353.843.943.652.243.433.392.712.982.322.091.230.311.27
FCF Conversion (FCF/Net Income)0.67x1.04x1.21x2.48x7.77x1.70x1.80x1.65x1.21x1.18x1.24x1.20x1.51x1.37x1.35x1.13x1.25x1.36x1.37x1.58x1.42x1.18x0.70x1.64x1.63x2.72x2.31x1.67x2.39x0.91x1.21x
Interest Paid122M122M97M102M99M89M89M89M87M75M78M79M104M76M129M123M131M149M161M153M00000000000
Taxes Paid104M104M264M347M73M100M303M241M207M245M347M323M236M312M263M292M295M301M275M299M00000000000

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Volatile quarterly cash conversion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Cash Conversion Swings Obscure Earnings Quality

According to the reported quarterly series, CLX's operating cash flow to net income ratio ranged from 0.84 to 2.23 over ten quarters, indicating that reported earnings are poorly anchored to cash generation in any single period.

The gap between net income and operating cash flow is the most important signal here, and it swings sharply in both directions, with a negative operating cash flow quarter in 2026Q3 offsetting a 2.02x conversion in 2026Q4. This pattern suggests that working capital timing and non-operating items, rather than steady operating performance, are driving the quarterly cash profile. Investors should monitor whether the trailing-year average conversion settles near 1.0x, which would support the earnings base, or remains structurally below it.

Free Cash Flow Margins Recovering from Trough

As reported in the quarterly cash flow statements, CLX free cash flow margin moved from a negative 9.9% in 2026Q3 to 12.5% in 2026Q4, though the series is highly uneven across the window.

Free cash flow has been positive in most quarters, but the 2026Q3 outflow of $165M shows how fragile the trajectory is when operating cash swings negative. The recovery toward a double-digit margin in 2026Q4 is encouraging, yet the most recent quarter of $105M in free cash flow reflects a low margin of 5.5%, suggesting the rebound has not yet been sustained. Investors should treat trailing averages with caution and watch whether the 2025Q3 to 2025Q4 margin levels of 11% to 14% can be reestablished.

Working Capital Drives Quarterly Cash Volatility

Based on reported figures, CLX working capital changes ranged from a $194M inflow to a $138M outflow across recent quarters, indicating that timing rather than structural cash generation is driving much of the variability.

The swing from a $194M working capital inflow in 2026Q4 to a $138M outflow in 2027Q1 is large relative to quarterly operating cash flow, suggesting receivables, inventory, or payables timing is a primary driver of reported cash. Such swings may indicate that the reported operating cash figures are more sensitive to quarter-end positioning than to the underlying demand trend. Investors should examine whether these reversals reflect seasonal inventory build or trade spend timing, and whether they fully reverse over the year.

Dividend Coverage Tight Against Cash Generation

According to the reported quarterly series, CLX paid roughly $150M in dividends in most quarters, a level that exceeded free cash flow in several periods including 2026Q3 and 2027Q1.

Dividends have been held at a near-constant run rate while free cash flow has fluctuated widely, meaning coverage was negative in 2026Q3 and thin in 2027Q1. Buybacks appear largely absent in recent quarters aside from a few periods, and acquisition outflows in 2025Q1 and 2026Q4 are notable against that backdrop. This pattern may suggest the dividend is being funded in part by balance sheet capacity, which warrants monitoring given the elevated leverage reported in the prior analysis.

Cash Recovery May Be Flattered by Timing

Based on reported filings, the strongest quarters in the series, including 2026Q4 and 2026Q2, coincide with large working capital inflows, which may overstate the underlying run-rate of cash generation.

Operating cash flow in 2026Q4 of $330M and 2026Q2 of $311M appear heavily supported by working capital movements rather than by a step-up in earnings, given net income of $163M and $157M respectively. Stripping out working capital effects would likely reduce the apparent conversion strength materially, a point consistent with the cyber-recovery distortion flagged in the prior income statement analysis. Investors should treat the recent cash recovery as provisional until it is validated across a full fiscal year.

CLX — Frequently Asked Questions

Quick answers to the most common questions about buying CLX stock.

How much cash does The Clorox Company (CLX) generate from operations?

The Clorox Company (CLX) generated $612.0M in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.

What is The Clorox Company's free cash flow?

The Clorox Company (CLX) generated $405.0M in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is The Clorox Company's capital expenditure (CapEx)?

The Clorox Company (CLX) spent $207.0M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does The Clorox Company distribute cash to shareholders?

In 2026, The Clorox Company (CLX) returned $602.0M to shareholders via cash dividends and spent $256.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.